Skip to main content

Table 3 Initial quality certification of FDC pediatric ARVs*

From: The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children

 

2000

2005

2007

2008

2009

2-in-1 FDCs

     

ABC60/3TC30

   

solid

 

3TC30/d4T6

   

dispersible

 

3TC60/D4T12

   

dispersible

 

3TC30/ZDV60

    

solid

LPV100/RTV25

 

solid

   

LPV80/RTV20 per ml

liquid

    

3-in-1 FDCs

     

ABC60/3TC30/ZDV60

    

solid

3TC30/NVP50/d4T6

  

dispersible

  

3TC60/NVP100/d4T12

  

dispersible

  

3TC30/NVP50/ZDV60

    

dispersible

  1. *recommended on 2006 WHO pediatric HIV/AIDS treatment guidelines
Back to article page

BMC Pediatrics

ISSN: 1471-2431

Contact us